News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Clinical characteristics of EGFR-ctDNA shedders in EGFR-NSCLC patients – RolfoLab
Marzia Del Re/qiagen.com
Dec 23, 2024, 12:51

Clinical characteristics of EGFR-ctDNA shedders in EGFR-NSCLC patients – RolfoLab

RolfoLab shared on X:

“Our paper open access ‘Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients’ great collaboration with Marzia Del Re and team.”

Clinical characteristics of EGFR-ctDNA shedders in EGFR-NSCLC patients - RolfoLab

Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients

Authors: Marzia Del Re et al.

Clinical characteristics of EGFR-ctDNA shedders in EGFR-NSCLC patients - RolfoLab

Andrea Sbrana Antonio Chella b cancer Carola Forte Christian Rolfo EGFR-mutant NSCLC Giovanna Irene Luculli Iacopo Petrini Leila Sadeghi Gol Martina Ruglioni Marzia Del Re OncoDaily Oncology Romano Danesi Stefania Crucitta
Special Coverage
Blog
Dec 23, 2024, 12:51
Clinical characteristics of EGFR-ctDNA shedders in EGFR-NSCLC patients - RolfoLab
Science
Dec 23, 2024, 12:47
Giuseppe Banna: Selpercatinib for RET fusion+ NSCLC by Benjamin Besse et al.
Blog
Dec 23, 2024, 12:47
Arsela Prelaj: The program of the 3rd edition of the AI for Oncology conference
Science
Dec 23, 2024, 12:33
Elizabeth McKenna: Multimodal Spatial Profiling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma
Science
Dec 23, 2024, 12:23
Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology
Science
Dec 23, 2024, 12:19
Anirban Maitra: Preclinical data on potential combination to overcome KRASi resistance
Blog
Dec 23, 2024, 12:11
Five articles suggested by Yüksel Ürün
Blog
Dec 23, 2024, 12:00
Bertrand Delsuc: Refreshed Breast Cancer Map
Drugs
Dec 23, 2024, 11:55
Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction
Blog
Dec 23, 2024, 11:48
Amplifying the voices of those with shared experiences of colorectal cancer - Healthful Stories
Dialogues
Dec 23, 2024, 11:45
Dr. Jason Luke's Journey in Immuno-Oncology Innovation
Career
Dec 23, 2024, 11:41
OncoInfluencers to Follow on Social Media: Howard Jack West